✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ResearchClinical EvidenceMedical EducationCannabis SciencePeer Review Why This MattersAcademic conferences drive the translation of research...
Cannabinoids, Autophagy, and Alzheimer’s Disease, What This Review Explores and What It Still Leaves Unproven
This 2026 review explores how cannabinoids might influence autophagy pathways relevant to Alzheimer’s disease. Its value is mainly mechanistic and hypothesis-building, with some discussion of early clinical and preclinical signals. It does not prove that cannabinoids currently offer established disease-modifying treatment for Alzheimer’s disease.
Cannabis & Cannabinoid Research – All Issues – Sage Journals
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ResearchEvidence-Based MedicineClinical PracticeAcademic PublishingCannabis Science Why This MattersAccess to peer-reviewed cannabis research through established...
Cannabis Research Institute | LinkedIn
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ResearchEvidenceClinical TrialsCannabis ScienceMedical Cannabis Why This MattersThe establishment of dedicated cannabis research institutes represents...
Yale and McGill Collaborate to Expand Cannabis Research
✦ New CED Clinical Relevance #78Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ResearchClinical EvidenceAcademic MedicineDrug DevelopmentCannabis Science Why This MattersAcademic partnerships between Yale and McGill represent...
When Confidence Replaces Competence: A Rebuttal to WSJ’s Cannabis Coverage
Cherry-picked studies and confident tone aren’t substitutes for scientific rigor. In today’s media landscape, it’s easy to mistake conviction for credibility—but real science demands nuance, context, and humility. This piece calls out the dangerous illusion of “Google expertise” and challenges us to raise the bar for what counts as informed commentary.
Cannabis and Dementia Risk: The Truth Behind the Scary Headline
A new study links cannabis-related ER visits to higher dementia risk—but the findings are more about hospital crises than cannabinoids. It’s not about everyday users, and it doesn’t prove causation. Here’s what this paper really tells us—and what it doesn’t.
Schedule I Drug Classification: 3 Times Science Was Ignored
This meme isn’t exaggeration—it’s history repeating itself in policy. [caption id="attachment_15936" align="aligncenter" width="550"] They said “no medical value.” Science disagrees.[/caption] The Schedule I drug classification was meant to indicate substances with...
10 Powerful Ways Cannabis Supports Children’s Behavior
Real-world stories of how cannabis brings calm, balance, and relief TL;DR Cannabis may offer relief for under-recognized behavioral challenges in children. Conditions like rage attacks, compulsive behaviors, and mood instability show early...
Cannabis 101: What Should You Really Know?
Cannabis 101: What Is Weed, Pot, or Marijuana—And What Should You Really Know? Is It 'Cannabis' or 'Weed'—and Why Does It Matter? What do you call it? Weed,...